Lv1
10 积分 2025-06-16 加入
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
1个月前
已完结
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial
1个月前
已完结
Prognostic implications of HER2 in ovarian cancer: Associations with homologous recombination deficiency and folate receptor alpha expression
1个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
2个月前
已完结
Navigating the complexities of drug development for inflammatory bowel disease
2个月前
已完结
Worldwide prevalence of prurigo nodularis: A systematic review and meta‐analysis
2个月前
已完结
Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus
2个月前
已完结
Prognostic implications of HER2 in ovarian cancer: Associations with homologous recombination deficiency and folate receptor alpha expression
2个月前
已完结
Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update)
4个月前
已关闭
皖公网安备34019202002308
